Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel · Delayed Price · Currency is ILS · Price in ILA 9,953.00
-137.00 (-1.36%)
At close: Jan 1, 2026
TLV:TEVA Market Cap
TLV:TEVA has a market cap or net worth of 114.15 billion as of December 31, 2025. Its market cap has increased by 69.23% in one year.
Market Cap
114.15B
Enterprise Value
161.63B
Revenue
55.55B
Ranking
n/a
PE Ratio
48.35
Stock Price
9,953.00
Market Cap Chart
Since June 26, 1992, TLV:TEVA's market cap has increased from 1.72B to 114.15B, an increase of 6,537.81%. That is a compound annual growth rate of 13.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 114.15B | 25.33% |
| Dec 31, 2024 | 91.08B | 116.11% |
| Dec 29, 2023 | 42.15B | 18.33% |
| Dec 30, 2022 | 35.62B | 29.61% |
| Dec 31, 2021 | 27.48B | -19.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.89B |
| Kamada | 1.31B |
| BrainsWay | 1.19B |
| SofWave Medical | 1.01B |
| Bait Bakfar | 991.66M |
| Ilex Medical | 749.38M |
| Novolog (Pharm-Up 1966) | 655.96M |
| Bonus BioGroup | 297.82M |